Amneal extended loan bid below OID; Veritiv, Buckeye Partners pricing guidance surfaces

By Sara Rosenberg

New York, Nov. 6 – Amneal Pharmaceuticals’ amended and extended term loan B was seen quoted in the secondary market on Monday below its original issue discount following allocations going out late Friday.

Meanwhile, in the primary market, Veritiv Corp. and Buckeye Partners LP released price talk on their term loans in connection with their lender calls.

Also, Everise (BCP V Everise Acquisition LLC), Hertz Corp. and Smyrna Ready Mix Concrete LLC joined this week’s new issue calendar.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.